Inventor · disambiguated record
Muhammad Safadi
Also filed as: SAFADI MUHAMMAD · SAFADI MUHAMMAD S
14 granted patents·15 pending applications·310 citations·filing 1998–2017
93Inventor score
Top patents by PatentIndex Score
29 records- 0196US7855233B2Citrate salt of RasagilineTEVA PHARMA·Filed 2010·Granted Dec 21, 2010·34 cites·16 claims
- 0294US6204257B1Water soluble prodrugs of hindered alcoholsUNIVERSTIY OF KANSAS·Filed 1998·Granted Mar 20, 2001·149 cites·28 claims
- 0390US8178127B2Stable laquinimod preparationsSAFADI MUHAMMAD·Filed 2008·Granted May 15, 2012·18 cites·16 claims
- 0490US8080584B2Delayed release rasagiline citrate formulationSAFADI MUHAMMAD·Filed 2009·Granted Dec 20, 2011·24 cites·41 claims
- 0589US6872838B2Water soluble prodrugs of hindered alcoholsUNIV KANSAS·Filed 2002·Granted Mar 29, 2005·25 cites·2 claims
- 0689US6451776B2Water soluble prodrugs of hindered alcoholsUNIV KANSAS·Filed 2000·Granted Sep 17, 2002·25 cites·9 claims
- 0787US9155775B1Process for manufacturing glatiramer acetate productCOHEN RAKEFET·Filed 2015·Granted Oct 13, 2015·16 cites·27 claims
- 0884US7244718B2Water soluble prodrugs of hindered alcoholsUNIV KANSAS·Filed 2004·Granted Jul 17, 2007·15 cites·7 claims
- 0977US8545885B2Stable laquinimod preparationsSAFADI MUHAMMAD·Filed 2012·Granted Oct 1, 2013·3 cites·20 claims
- 1070US9763993B2Process for manufacturing glatiramer acetate productTEVA PHARMA·Filed 2015·Granted Sep 19, 2017·1 cites·35 claims
- 1161US9340307B2Stable laquinimod preparationsTEVA PHARMA·Filed 2013·Granted May 17, 2016·0 cites·15 claims
- 1259US2014186514A1Delayed release rasagiline formulationSAFADI MUHAMMAD·Filed 2013·Application pending·0 cites
- 1358US2009181086A1Rasagiline formulations, their preparation and useSAFADI MUHAMMAD·Filed 2009·Application pending·0 cites
- 1456US2012263789A1Delayed release rasagiline formulationSAFADI MUHAMMAD·Filed 2012·Application pending·0 cites
- 1555US2012100189A1Delayed release rasagiline malate formulationSAFADI MUHAMMAD·Filed 2011·Application pending·0 cites
- 1653US2018000884A1Process for manufacturing glatiramer acetate productCOHEN RAKEFET·Filed 2017·Application pending·0 cites
- 1753US2018036363A1Process for manufacturing glatiramer acetate productCOHEN RAKEFET·Filed 2017·Application pending·0 cites
- 1852US2017196930A1Process for manufacturing glatiramer acetate productCOHEN RAKEFET·Filed 2017·Application pending·0 cites
- 1951US2012003310A1Delayed release rasagiline formulationSAFADI MUHAMMAD·Filed 2010·Application pending·0 cites
- 2048US9284276B2N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2013·Granted Mar 15, 2016·0 cites·17 claims
- 2147US2010008983A1Rasagiline soft gelatin capsulesSAFADI MUHAMMAD·Filed 2009·Application pending·0 cites
- 2246US9346746B2R(+)-N-formyl-propargyl-aminoindanTEVA PHARMA·Filed 2012·Granted May 24, 2016·0 cites·24 claims
- 2345US9339469B2R(+)-N-methyl-propargyl-aminoindanTEVA PHARMA·Filed 2012·Granted May 17, 2016·0 cites·21 claims
- 2442US2013089611A1Rasagiline citramideTEVA PHARMA·Filed 2012·Application pending·0 cites
- 2542US2017065576A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 2640US2016151345A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 2740US2016151346A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 2838US2017020854A1Pridopidine base formulations and their useLICHT DANIT·Filed 2016·Application pending·0 cites
- 2934US2014018386A1Laquinimod formulations without alkalizing agentSARFATI GADI·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Muhammad Safadi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →